Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.3300
0.00 (0.00%)
At close: Aug 7, 2026

Cleo Diagnostics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
2.560.850.21--
Revenue Growth
203.17%300.91%---
Gross Profit
2.560.850.21--
Operating Income
-3.87-4.08-3.64-1.7-0.07
Net Income
-4.03-4-3.76-1.73-0.08
Earnings Per Share
-0.03-0.03-0.03-0.07-
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
9.436.469.370.24-
Total Debt
---1.6-
Net Cash (Debt)
9.436.469.37-1.36-
Net Cash Growth
45.91%-31.07%---
Net Cash Per Share
0.070.050.08-0.05-

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-2.51-2.9-2.03-0.68-
Capital Expenditures
-0.01-0.01-0-0.04-
Free Cash Flow
-2.52-2.91-2.03-0.72-
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%--
Operating Margin
-151.15%-483.01%-1727.45%--
Pretax Margin
-157.36%-473.17%-1783.22%--
Profit Margin
-157.36%-473.17%-1783.22%--
FCF Margin
-98.35%-344.57%-964.47%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
17.6659.30207.25--